This is a beta version of OpenPrescribing Hospitals for testing and feedback purposes. Data and functionality may be incomplete. Please contact us if you find any issues or have feedback. Sign up for email alerts to stay updated.

Measures

Measures are pre-built analyses of medicines use in hospitals. They provide valuable insights into areas such as cost-effectiveness, patient safety, and adherence to best practices.

Just because an NHS Trust is an outlier for high or low use, that doesn't necessarily mean they are good or bad. These are measures rather than indicators, and they need to be interpreted judiciously.

Best Value DOACs

Percentage of DOACs that are not rivaroxaban or apixaban tablets.

Tags: Value

This measure supports cost saving work in hospitals.

View measure

🆕

Discontinuation of insulin detemir

Total count of insulin detemir pre-filled devices / cartridges issued.

Tags: Safety

This measure supports medicines safety work to reduce risk and minimise mistakes in hospitals.

View measure

Environmentally friendly inhalers

Percentage of inhaler doses that are from metered dose inhalers (MDIs), excluding salbutamol inhalers.

Tags: Greener NHS

This measure supports work to reduce the impact of medicines issued in hospitals on the overall environmental impact of the NHS.

View measure

Low value prescribing - co-proxamol

Total indicative cost for co-proxamol tablets and oral suspension

Tags: Safety

This measure supports medicines safety work to reduce risk and minimise mistakes in hospitals.

Value

This measure supports cost saving work in hospitals.

Low value prescribing

This measure supports work to reduce low value prescribing in hospitals.

View measure

Low value prescribing - doxazosin modified release

Percentage of doxazosin modified release of all doxazosin issued.

Tags: Value

This measure supports cost saving work in hospitals.

Low value prescribing

This measure supports work to reduce low value prescribing in hospitals.

View measure

Low value prescribing - lidocaine plasters

Total lidocaine plasters issued

Tags: Value

This measure supports cost saving work in hospitals.

Low value prescribing

This measure supports work to reduce low value prescribing in hospitals.

View measure

Low value prescribing - perindopril arginine

Percentage of perindopril arginine of all perindopril.

Tags: Value

This measure supports cost saving work in hospitals.

Low value prescribing

This measure supports work to reduce low value prescribing in hospitals.

View measure

Methotrexate tablets

Percentage of methotrexate tablets which are 10mg

Tags: Safety

This measure supports medicines safety work to reduce risk and minimise mistakes in hospitals.

View measure

SGLT-2 inhibitors

The proportion of sodium-glucose co-transporter 2 (SGLT-2) inhibitors (excluding combination products) not prescribed as dapagliflozin tablets. Combination products are excluded as they do not have specified [Defined Daily Doses (DDDs)](/faq/#what-is-a-defined-daily-dose-ddd) and the quantity of SGLT-2 inhibitors issued as combinations is low. There is a similar measure on [OpenPrescribing](https://openprescribing.net/measure/dapagliflozin/) for primary care, which reports the use of generic dapagliflozin. In OpenPrescribing Hospitals, [branded and generic products cannot be distinguished](https://www.bennett.ox.ac.uk/blog/2025/07/you-asked-can-we-monitor-the-usage-of-biosimilars-in-secondary-care-using-openprescribing-hospitals/). For this reason, we report dapagliflozin use as a proportion of all SGLT-2 inhibitor use.

Tags: Low value prescribing

This measure supports work to reduce low value prescribing in hospitals.

View measure